Coloplast A/S (CLPBY)
12.56
+0.20
(+1.62%)
USD |
OTCM |
May 17, 16:00
Coloplast Total Liabilities (Quarterly): 4.620B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 4.620B |
| December 31, 2023 | 4.969B |
| September 30, 2023 | 4.371B |
| June 30, 2023 | 4.173B |
| March 31, 2023 | 4.138B |
| December 31, 2022 | 4.219B |
| September 30, 2022 | 3.853B |
| June 30, 2022 | 3.919B |
| March 31, 2022 | 4.186B |
| December 31, 2021 | 1.487B |
| September 30, 2021 | 1.197B |
| June 30, 2021 | 1.365B |
| March 31, 2021 | 1.310B |
| December 31, 2020 | 1.513B |
| September 30, 2020 | 960.71M |
| June 30, 2020 | 1.049B |
| March 31, 2020 | 1.025B |
| December 31, 2019 | 1.165B |
| September 30, 2019 | 852.72M |
| June 30, 2019 | 1.007B |
| March 31, 2019 | 919.56M |
| December 31, 2018 | 1.060B |
| September 30, 2018 | 832.56M |
| June 30, 2018 | 1.158B |
| March 31, 2018 | 1.219B |
| Date | Value |
|---|---|
| December 31, 2017 | 1.206B |
| September 30, 2017 | 965.19M |
| June 30, 2017 | 1.121B |
| March 31, 2017 | 1.070B |
| December 31, 2016 | 1.233B |
| September 30, 2016 | 893.82M |
| June 30, 2016 | 1.014B |
| March 31, 2016 | 863.44M |
| December 31, 2015 | 993.72M |
| September 30, 2015 | 921.78M |
| June 30, 2015 | 624.17M |
| March 31, 2015 | 601.19M |
| December 31, 2014 | 696.84M |
| September 30, 2014 | 698.20M |
| June 30, 2014 | 676.55M |
| March 31, 2014 | 631.75M |
| December 31, 2013 | 428.11M |
| September 30, 2013 | 505.70M |
| June 30, 2013 | 433.68M |
| March 31, 2013 | 638.67M |
| December 31, 2012 | 682.73M |
| September 30, 2012 | 715.80M |
| June 30, 2012 | 766.84M |
| March 31, 2012 | 775.21M |
| December 31, 2011 | 779.99M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
852.72M
Minimum
Sep 2019
4.969B
Maximum
Dec 2023
2.569B
Average
1.500B
Median
Total Liabilities (Quarterly) Benchmarks
| Genmab A/S | 605.09M |
| Ascendis Pharma A/S | 1.124B |
| Galecto Inc | 4.318M |
| Evaxion Biotech AS | 17.63M |
| IO Biotech Inc | 12.69M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.964B |
| Shareholders Equity (Quarterly) | 2.343B |
| Debt to Equity Ratio | 1.449 |
| Current Ratio | 0.6005 |
| Net Debt Paydown Yield | -0.21% |